Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

MAP Pharmaceuticals Announces Termination Of Pediatric Asthma Collaboration
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that it has received a notice of termination of the license agreement with AstraZeneca related to the company"s Unit Dose Budesonide (UDB) product candidate. The termination was received on July 8, 2009, effective immediately. All rights licensed to AstraZeneca in the agreement now revert to the company. MAP Pharmaceuticals plans to suspend development of UDB, which did not meet primary endpoints in a Phase 3 trial in children 12-months to eight years of age with mild asthma.
generic viagra online
Obama's Focus On Health Care Crucial To Reform
"After a week of international diplomacy, President Obama returns to Washington this week facing an even greater diplomatic challenge: nudging the large and controversial health-care reform package toward consensus on Capitol Hill," The Washington Post reports. Despite media reports of challenges including "the virtual wall of opposition among Republicans," "resistance among conservative Blue Dog Democrats over the potential cost," and "nervousness among progressives that the White House might compromise too much on a public insurance option," officials at the White House "remain publicly optimistic." White House Chief of Staff Rahm Emanuel said that the issues are just part of "the nature of what we"re doing," and that "we"ve never, on universal coverage, been this close to the goal line."
News of the day
Latin America Accounts For Two-Thirds Of All Confirmed H1N1 Deaths
Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region "which accounts for around two-thirds of the 816 confirmed deaths so far from the disease," the AFP/channelnewsasia.com reports. "The outlook is especially unsettling for the estimated 380 million people grappling with winter in South America, where the A(H1N1) virus is speedily propagating," the news service writes. The article examines the number of H1N1 cases and deaths across countries and how government officials are working to prevent the spread of the virus (7/29).
Oncology

Dangerous Legal Loophole Must Be Closed, Society Warns

The Royal Pharmaceutical Society of Great Britain (RPSGB) is demanding the closure of a legal loophole which allows non-pharmacy retailers to sell dangerously large amounts of paracetamol. The RPSGB became concerned last week when it was informed a Poundland store in Kent was selling 48 tablets of the painkiller for just ÷£1.00. The RPSGB"s Director of Policy, David Pruce said: "It is extremely worrying to know people may purchase this medicine without any consultation or guidance and inadvertently use it incorrectly. We know that limiting the amount of paracetamol sold at one time has reduced the number of deaths from paracetamol poisoning" Over a decade ago, the Medicines and Healthcare products Regulatory Agency (MHRA) limited the paracetamol pack size in non-pharmacy retailers to 16 tablets - but allowed up to six packs to be sold at a time. Most stores, including pharmacies, will only sell a maximum of two packs at a time. David Pruce said: "I urge members of the public to see their local community pharmacist if they are in need of medicines. Pharmacists are well-placed to give people expert advice and care, and are conveniently located on the high streets of most towns. In addition, the public can be sure medicines bought from a registered pharmacy would have met strict quality control standards, and would have been manufactured to UK requirements." The Royal Pharmaceutical Society of Great Britain


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009